Oct 6- Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical common stock, giving the drugmaker a stake of about 16.6 percent. Skadden, Arps, Slate, Meagher&...
CNBC's Meg Tirrell reports the latest details surrounding Johnson & Johnson and the cyber hack of one of the company's medical devices. Jay Radcliffe, Rapid7 senior security consultant, weighs in.
TORONTO, Oct 3- Canada's main stock index fell on Monday, as major gold miners lost ground and heavyweight banks also pulled back as the federal government tightened mortgage and tax rules in a bid to cool the housing market. The most influential stocks weighing on the index included Goldcorp Inc which fell 4.5 percent to C $20.68 after it temporarily shut down...
Oct 3- Spectral Medical Inc said its experimental treatment for sepsis- a common, oft-deadly complication of infection- failed a late-stage study, stymieing the company's plans to bring to market the first FDA- approved device for the condition. "We proved beyond doubt that endotoxin is bad and taking it out is good," and Spectral will discuss with the U.S. Food and...
Oct 3- Spectral Medical Inc said its experimental treatment for sepsis- a common, oft-deadly complication of infection- failed a late-stage study, stymieing the company's plans to bring to market the first FDA- approved device for the condition. There are no specific FDA- approved medicines for the treatment of sepsis, and there have been several high-profile...
The U.S. Food and Drug Administration, in its approval of the device, the MiniMed 670 G, hailed it as a breakthrough. Jeffrey Shuren, director of the FDA's medical device division, said in a statement. Analysts said the FDA approved the device six months sooner than expected.
Sept 28- The U.S. Food and Drug Administration on Wednesday approved Medtronic Plc's "artificial pancreas" designed to automatically deliver the right dose of insulin to patients with type 1 diabetes. Jeffrey Shuren, director of the FDA's medical device division said in a statement. "This device will mean peace of mind, in knowing a person will be in normal blood...
St. Jude reopens, with fractionally higher stocks, CNBC's Bob Pisani reports.
Check out the companies making headlines after the bell Tuesday.
HeartWare stock soared more than 90 percent on news that the company will be acquired by Medtronic.
CNBC's Diana Olick takes a look at bringing deskercise to the classroom.
Thermo Fisher Scientific said it would buy FEI for about $4.2 billion to gain access to its signature electron microscopy technology.
An invention that debuted Thursday could let you see all the spots you're missing when you brush.
A team at Oxford University have used virtual reality devices to help treat patients with paranoia, showing how VR could help health care.
NBC News' Maria Shriver reports on her exclusive interview with Theranos CEO Elizabeth Holmes and the executive's resolve to correct its lab testing issues.
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.
Bill Ackman should have listened!
Ben Young, Sworkit founder & CEO, explains how a new fitness app allows users to customize personalized workout videos.
Loncar Investments CEO, Brad Loncar says immunotherapy is the most innovative, high-growth area in the biotech space, while describing the company’s ETF.
Toshiba has granted Canon exclusive negotiating rights for its medical equipment unit after a hotly contested auction.